← Back to Search

Interoceptive Exposure for Anxiety

N/A

Waitlist Available

Research Sponsored by G.V. (Sonny) Montgomery VA Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months

Awards & highlights

Study Summary

This trial is testing whether Interoceptive Exposure (IE) can help reduce negative thoughts and arousal in veterans with PTSD during an anxiety-inducing situation.

Who is the study for?

This trial is for OEF/OIF veterans with combat-related PTSD, probable PTSD diagnosis (PTSD Checklist score >44), high anxiety sensitivity (ASI score >28), and medical clearance. Excluded are those with conditions affecting study participation or data integrity, such as uncontrolled blood pressure, severe asthma, dementia, psychotic disorders, acute mania, current substance abuse or certain medications.Check my eligibility

What is being tested?

The trial tests Interoceptive Exposure (IE) to reduce negative thoughts and arousal in anxious situations among veterans with PTSD. Participants undergo IE or supportive counseling over four weeks at GVSMVAMC and are assessed before and after treatment using interviews, self-reports, and a social stressor task.See study design

What are the potential side effects?

While the specific side effects of Interoceptive Exposure aren't detailed here since it's a psychological intervention rather than a drug therapy; participants may experience increased anxiety or discomfort when exposed to the sensations of arousal during sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anxiety Sensitivity Index-3

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: IEExperimental Treatment1 Intervention

Participants will complete an at home four-week, intervention targeting their negative cognitions triggered by physical sensations. The goal of IE is to purposefully induce bodily sensations related to autonomic arousal so that participants can learn that those sensations are not harmful. IE and Cognitive restructuring have been found to be superior to progressive muscle relaxation as a way to avoid aversive autonomic sensations.

Group II: 2Active Control1 Intervention

waitlist control

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

G.V. (Sonny) Montgomery VA Medical CenterLead Sponsor

2 Previous Clinical Trials

70 Total Patients Enrolled

Media Library

Interoceptive Exposure Clinical Trial Eligibility Overview. Trial Name: NCT00795379 — N/A

Anxiety Clinical Trial 2023: Interoceptive Exposure Highlights & Side Effects. Trial Name: NCT00795379 — N/A

Interoceptive Exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT00795379 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial actively seeking participants?

"Clinicaltrials.gov states that this trial, which began accepting patients on November 1st 2008, is not currently recruiting any individuals for research purposes. However, there are 375 other trials open to the public at present time."

Answered by AI

Does this trial accept senior citizens as participants?

"This trial dictates that viable participants must be between 18 and 65 years of age."

Answered by AI

Do I meet the requirements to participate in this clinical experiment?

"To qualify as a subject in this trial, applicants must be afflicted with anxiety and fall within the 18-65 age range. The total amount of participants being enrolled is 40 people."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing the Use of Interoceptive Exposure to Reduce Barriers to Psychotherapy

2008. "Testing the Use of Interoceptive Exposure to Reduce Barriers to Psychotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00795379.

All > Mississippi